Disposition Activity -- Q3 proceeds totaled $19.3 million, with $4.6 million in gains; year-to-date sales reached $133.8 ...

Both of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.

to its investors that increases over time. The REIT has certainly succeeded in that mission over the years. It has raised its ...

Net Income -- $7.6 million, down from $9.3 million. Net income attributable to Karat ( KRT +1.51%) was $7.3 million, or $0.36 ...

Total Revenue -- $21.2 million for the third quarter of 2025, up 16%, driven by MRI compatible IV infusion pump and ...

One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Q4 2025 guidance -- Projected total revenue of $371 million to $377 million; subscription revenue of $258 million to $261 ...

Exclusive Supply Agreement: A contractual arrangement where UFP Technologies ( UFPT 2.21%) is the sole supplier of specified ...

A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.

PN-943 (IBD Program) -- Oral, gut-restricted alpha-4-beta-7 integrin antagonist demonstrated greater than threefold improved ...

These three low-cost funds offer exposure to international dividends, U.S. technology, and small-cap value -- the building ...

If you are looking to expand your investments in AI but want to diversify your portfolio away from chip stocks, I think one ...